Analysis of variants in untranslated and promoter regions and breast cancer risk using whole genome sequencing data

Naomi Wilcox, Jonathan P. Tyrer, Leila Dorling, Joe Dennis, Marc Naven, Mustapha Abubakar, Thomas U. Ahearn, Irene L. Andrulis, Antonis C. Antoniou, Natalia V. Bogdanova, Stig E. Bojesen, Manjeet K. Bolla, Hiltrud Brauch, Nicola J. Camp, Jenny Chang-Claude, Kamila Czene, Thilo Dörk, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Eugene J. Gardner, Anna González-Neira, Pascal Guénel, Eric Hahnen, Per Hall, Mikael Hartman, Maartje J. Hooning, Anna Jakubowska, Elza K. Khusnutdinova, Vessela N. Kristensen, Jingmei Li, Annika Lindblom, Artitaya Lophatananon, Arto Mannermaa, Siranoush Manoukian, Roger L. Milne, Rocio Nuñez-Torres, Nadia Obi, Mihalis I. Panayiotidis, Sue K. Park, John R.B. Perry, Muhammad U. Rashid, Emmanouil Saloustros, Elinor J. Sawyer, Marjanka K. Schmidt, Melissa C. Southey, Amanda B. Spurdle, Diana Torres, Qin Wang, Jacques Simard, Soo Hwang Teo, Alison M. Dunning, Peter Devilee, Douglas F. Easton
doi: https://doi.org/10.1101/2024.07.03.24309763

Article Information

doi 
https://doi.org/10.1101/2024.07.03.24309763
History 
  • July 5, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Naomi Wilcox1,*,
  2. Jonathan P. Tyrer1,
  3. Leila Dorling1,
  4. Joe Dennis1,
  5. Marc Naven1,
  6. Mustapha Abubakar2,
  7. Thomas U. Ahearn2,
  8. Irene L. Andrulis3,4,
  9. Antonis C. Antoniou1,
  10. Natalia V. Bogdanova5,6,7,
  11. Stig E. Bojesen8,9,10,
  12. Manjeet K. Bolla1,
  13. Hiltrud Brauch11,12,13,
  14. Nicola J. Camp14,
  15. Jenny Chang-Claude15,16,
  16. Kamila Czene17,
  17. Thilo Dörk6,
  18. D. Gareth Evans18,19,
  19. Peter A. Fasching20,
  20. Jonine D. Figueroa2,21,22,
  21. Henrik Flyger23,
  22. Eugene J. Gardner24,
  23. Anna González-Neira25,
  24. Pascal Guénel26,
  25. Eric Hahnen27,28,
  26. Per Hall17,29,
  27. Mikael Hartman30,31,32,
  28. Maartje J. Hooning33,
  29. Anna Jakubowska34,35,
  30. Elza K. Khusnutdinova36,37,
  31. Vessela N. Kristensen38,39,
  32. Jingmei Li40,
  33. Annika Lindblom41,42,
  34. Artitaya Lophatananon43,
  35. Arto Mannermaa44,45,46,
  36. Siranoush Manoukian47,
  37. Roger L. Milne48,49,50,
  38. Rocio Nuñez-Torres51,
  39. Nadia Obi52,53,
  40. Mihalis I. Panayiotidis54,
  41. Sue K. Park55,56,57,
  42. John R.B. Perry24,58,
  43. Muhammad U. Rashid59,60,
  44. Emmanouil Saloustros61,
  45. Elinor J. Sawyer62,
  46. Marjanka K. Schmidt63,64,65,
  47. Melissa C. Southey48,50,66,
  48. Amanda B. Spurdle67,
  49. Diana Torres59,68,
  50. Qin Wang1,
  51. Jacques Simard69,
  52. Soo Hwang Teo70,71,
  53. Alison M. Dunning72,
  54. Peter Devilee73,74 and
  55. Douglas F. Easton1,72
  1. 1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
  2. 2Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
  3. 3Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada
  4. 4Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada
  5. 5Department of Radiation Oncology, Hannover Medical School, Hannover, Germany
  6. 6Gynaecology Research Unit, Hannover Medical School, Hannover, Germany
  7. 7N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus
  8. 8Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark
  9. 9Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark
  10. 10Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  11. 11Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany
  12. 12iFIT-Cluster of Excellence, University of Tübingen, Tübingen, Germany
  13. 13German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany
  14. 14Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
  15. 15Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
  16. 16Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  17. 17Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
  18. 18Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
  19. 19North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
  20. 20Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany
  21. 21Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK
  22. 22Cancer Research UK Edinburgh Centre, The University of Edinburgh, Edinburgh, UK
  23. 23Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark
  24. 24MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
  25. 25Human Genotyping Unit-CeGen, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
  26. 26Team ‘Exposome and Heredity’, CESP, Gustave Roussy, INSERM, University Paris-Saclay, UVSQ, Villejuif, France
  27. 27Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  28. 28Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  29. 29Department of Oncology, Södersjukhuset, Stockholm, Sweden
  30. 30Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore
  31. 31Department of Surgery, National University Health System, Singapore City, Singapore
  32. 32Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore
  33. 33Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
  34. 34Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland
  35. 35International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland
  36. 36Institute of Biochemistry and Genetics of the Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia
  37. 37Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia
  38. 38Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway
  39. 39Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
  40. 40Human Genetics Division, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore
  41. 41Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
  42. 42Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden
  43. 43Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
  44. 44Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland
  45. 45Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland
  46. 46Biobank of Eastern Finland, Kuopio University Hospital, Kuopio, Finland
  47. 47Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
  48. 48Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia
  49. 49Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
  50. 50Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia
  51. 51Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
  52. 52Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  53. 53Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  54. 54Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus
  55. 55Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea
  56. 56Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, Korea
  57. 57Cancer Research Institute, Seoul National University, Seoul, Korea
  58. 58Metabolic Research Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
  59. 59Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
  60. 60Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan
  61. 61Department of Oncology, University Hospital of Larissa, Larissa, Greece
  62. 62School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy’s Campus, King’s College London, London, UK
  63. 63Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
  64. 64Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands
  65. 65Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands
  66. 66Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia
  67. 67Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
  68. 68Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia
  69. 69Genomics Center, Centre Hospitalier Universitaire de Québec – Université Laval Research Center, Québec City, Québec, Canada
  70. 70Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia
  71. 71Department of Surgery, Faculty of Medicine, University of Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia
  72. 72Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
  73. 73Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands
  74. 74Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands
  1. ↵*Corresponding author; Email: naw41{at}medschl.cam.ac.uk
Back to top
Posted July 05, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Analysis of variants in untranslated and promoter regions and breast cancer risk using whole genome sequencing data
Naomi Wilcox, Jonathan P. Tyrer, Leila Dorling, Joe Dennis, Marc Naven, Mustapha Abubakar, Thomas U. Ahearn, Irene L. Andrulis, Antonis C. Antoniou, Natalia V. Bogdanova, Stig E. Bojesen, Manjeet K. Bolla, Hiltrud Brauch, Nicola J. Camp, Jenny Chang-Claude, Kamila Czene, Thilo Dörk, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Eugene J. Gardner, Anna González-Neira, Pascal Guénel, Eric Hahnen, Per Hall, Mikael Hartman, Maartje J. Hooning, Anna Jakubowska, Elza K. Khusnutdinova, Vessela N. Kristensen, Jingmei Li, Annika Lindblom, Artitaya Lophatananon, Arto Mannermaa, Siranoush Manoukian, Roger L. Milne, Rocio Nuñez-Torres, Nadia Obi, Mihalis I. Panayiotidis, Sue K. Park, John R.B. Perry, Muhammad U. Rashid, Emmanouil Saloustros, Elinor J. Sawyer, Marjanka K. Schmidt, Melissa C. Southey, Amanda B. Spurdle, Diana Torres, Qin Wang, Jacques Simard, Soo Hwang Teo, Alison M. Dunning, Peter Devilee, Douglas F. Easton
medRxiv 2024.07.03.24309763; doi: https://doi.org/10.1101/2024.07.03.24309763
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area